Informed Consent Template by Strategic Initiative for Developing Capacity in Ethical Review. A Good Alternate?

K. V. Chary
{"title":"Informed Consent Template by Strategic Initiative for Developing Capacity in Ethical Review. A Good Alternate?","authors":"K. V. Chary","doi":"10.5530/PTB.2018.4.1","DOIUrl":null,"url":null,"abstract":"Correspondence: Dr. Krishnan Vengadaragava Chary Department of Pharmacology, Saveetha Medical College, Chennai 602105, Tamil Nadu, INDIA. Phone no: 9894930069 Email: doctorkrishforu@gmail.com DOI: 10.5530/PTB.2018.4.1 Obtaining informed consent from (ICF) the participants of a clinical trial, bioavailability and bioequivalence studies, and investigator initiated research consists of two documents; participants’ information sheet and informed consent form. Informed consent is also a mandate for epidemiological and observational studies. It ensure participants autonomy to enroll them in trials and also legally valid for their post trial access and compensation. As a dictum, it should be in English and vernacular language signed by study subjects or their legally accepted representative (LAR).1 There are valid differences in opinion about amount of information that should be in given consent form. Participant information sheet in too much number of pages is often perceived tedious by the subjects and it is more complex when it comes to countries like India where there is diversity in language; Whereas it is an important for a sponsor and investigator to disclose all the elements, for an example, all the possible and rare adverse effects in the information to protect them from legal liability. Patient’s ability to understand and thereby willing to participate in a study is challenged by amount of information and its simplicity. Too lengthy and complexity in understanding them is seen even in western scenario. In a study conducted by Hames B et al. in 2016 among Netherlands, Denmark and Norway population concluded that readability is not within acceptable range of the study subject’s educational profile. This sort of assessment scale [Gunning’s fog index] is neither developed nor adopted in our scenario.2-3 Utilizing the commonly made information sheet with back translation in vernacular language cannot be relied as simple and understandable by the all the participants and patients often tend to overlook essential elements in the information sheet. Study data comprehensiveness is one of the major tasks to be tackled to achieve patient’s participants in our trial on their own. In order to develop comprehensive information sheet and consent form, Strategic Initiative for Developing Capacity in Ethical Review (SIDCER), an independent global network, supported by World health organization (WHO) for raising standards of ethics developed a model format containing all relevant materials of an informed consent. Highlights of SIDCER form is given in Table 1. S No SICDER ICF Template features","PeriodicalId":416050,"journal":{"name":"Pharmacology, Toxicology and Biomedical Reports","volume":"123 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacology, Toxicology and Biomedical Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5530/PTB.2018.4.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Correspondence: Dr. Krishnan Vengadaragava Chary Department of Pharmacology, Saveetha Medical College, Chennai 602105, Tamil Nadu, INDIA. Phone no: 9894930069 Email: doctorkrishforu@gmail.com DOI: 10.5530/PTB.2018.4.1 Obtaining informed consent from (ICF) the participants of a clinical trial, bioavailability and bioequivalence studies, and investigator initiated research consists of two documents; participants’ information sheet and informed consent form. Informed consent is also a mandate for epidemiological and observational studies. It ensure participants autonomy to enroll them in trials and also legally valid for their post trial access and compensation. As a dictum, it should be in English and vernacular language signed by study subjects or their legally accepted representative (LAR).1 There are valid differences in opinion about amount of information that should be in given consent form. Participant information sheet in too much number of pages is often perceived tedious by the subjects and it is more complex when it comes to countries like India where there is diversity in language; Whereas it is an important for a sponsor and investigator to disclose all the elements, for an example, all the possible and rare adverse effects in the information to protect them from legal liability. Patient’s ability to understand and thereby willing to participate in a study is challenged by amount of information and its simplicity. Too lengthy and complexity in understanding them is seen even in western scenario. In a study conducted by Hames B et al. in 2016 among Netherlands, Denmark and Norway population concluded that readability is not within acceptable range of the study subject’s educational profile. This sort of assessment scale [Gunning’s fog index] is neither developed nor adopted in our scenario.2-3 Utilizing the commonly made information sheet with back translation in vernacular language cannot be relied as simple and understandable by the all the participants and patients often tend to overlook essential elements in the information sheet. Study data comprehensiveness is one of the major tasks to be tackled to achieve patient’s participants in our trial on their own. In order to develop comprehensive information sheet and consent form, Strategic Initiative for Developing Capacity in Ethical Review (SIDCER), an independent global network, supported by World health organization (WHO) for raising standards of ethics developed a model format containing all relevant materials of an informed consent. Highlights of SIDCER form is given in Table 1. S No SICDER ICF Template features
伦理审查能力发展战略倡议的知情同意模板。一个好的替代方案?
通讯:Krishnan Vengadaragava Chary博士,savetha医学院药学系,印度泰米尔纳德邦金奈602105。电话号码:9894930069电子邮件:doctorkrishforu@gmail.com DOI: 10.5530/PTB.2018.4.1获得临床试验(ICF)参与者的知情同意,生物利用度和生物等效性研究,以及研究者发起的研究包括两份文件;参与者信息表和知情同意书。知情同意也是流行病学和观察性研究的一项任务。它确保参与者自主报名参加试验,并在法律上有效地为他们的试验后访问和补偿。作为格言,应由研究对象或其法定代理人(LAR)以英语和当地语言签署对于同意书中应该包含多少信息,人们的意见存在有效的分歧。过多页数的参与者信息表通常会被受试者认为冗长乏味,而在印度等语言多样性的国家,情况会更加复杂;而对于发起人和研究者来说,披露信息中所有可能的和罕见的不利影响,以保护他们免于承担法律责任是很重要的。患者理解并因此愿意参与研究的能力受到信息量和简单性的挑战。即使在西方的场景中,理解它们也过于冗长和复杂。2016年,Hames B等人对荷兰、丹麦和挪威人口进行的一项研究得出结论,可读性不在研究对象教育背景的可接受范围内。在我们的场景中,既没有开发也没有采用这种评估量表(冈宁雾指数)。2-3使用通常制作的带有白话反译的信息表不能让所有参与者都简单易懂,患者往往会忽略信息表中的基本要素。研究数据的全面性是需要解决的主要任务之一,以实现患者参与我们的试验自己。为了制定全面的信息表和同意书,由世界卫生组织(世卫组织)支持的一个提高道德标准的独立全球网络——道德审查能力发展战略倡议(SIDCER)制定了一个包含知情同意的所有相关材料的示范格式。表1给出了SIDCER表单的要点。没有SICDER ICF模板功能
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信